Anticoagulation Is Associated with Decreased Inferior Vena Cava Filter-Related Complications in Patients with Metastatic Carcinoma - 18/04/17
Abstract |
Objectives |
Patients with metastatic carcinoma and venous thromboembolism commonly have contraindications to anticoagulation that prompt the use of retrievable inferior vena cava filters. The aim of this study was to compare the pattern of inferior vena cava filter use, anticoagulation management, and development of inferior vena cava filter-related complications in patients with localized versus metastatic carcinoma.
Methods |
We conducted a retrospective cohort study of inferior vena cava filter use at a tertiary referral hospital between January 1, 2009, and December 31, 2011. Including only patients with cancer and carcinomas, both metastatic and localized, we recorded the indications for inferior vena cava filter, postfilter practices including anticoagulation use, filter retrieval rates, and filter-related complications.
Results |
Overall, 154 patients with carcinoma underwent inferior vena cava filter placement. Basic demographics and indication for filter placement were similar between the metastatic and localized groups. Metastatic patients had more filter-related complications (25% vs 11%, P = .03) and underwent filter retrieval less often (31% vs 58%, P = .01). Time to reinitiating anticoagulation was longer in metastatic patients (5.5 vs 2 days, P = .05). In multivariate analysis, metastatic disease was associated with reduced inferior vena cava filter retrieval (odds ratio, 0.3; P = .003). Anticoagulation use was associated with a lower rate of filter-related complications (odds ratio, 0.3; P = .005).
Conclusions |
Patients with metastatic carcinoma with an indwelling inferior vena cava filter had a higher rate of filter-related complications, a lower filter retrieval rate, and a greater median time to initiating anticoagulation. When possible, early reinitiation of anticoagulation may reduce inferior vena cava filter-related complications.
Le texte complet de cet article est disponible en PDF.Keywords : Anticoagulants, Carcinoma, Inferior vena cava filters, Metastatic cancer, Venous thromboembolism
Plan
| Funding: None. |
|
| Conflict of Interest: MRJ reports nonfinancial support from Boston Scientific, nonfinancial support from Cordis Corporation, and personal fees from Cardinal Health, Bi02/Novella, Volcano, VIVA Physicians, a 501 c 3 not-for-profit education and research organization, and the Society for Cardiovascular Angiography and Intervention, outside the submitted work. |
|
| Authorship: All authors had access to the data and played a role in writing this manuscript. |
Vol 130 - N° 1
P. 77 - janvier 2017 Retour au numéro
Article précédent
- Mitral Regurgitation and Increased Risk of All-Cause and Cardiovascular Mortality in Patients with Type 2 Diabetes
- Andrea Rossi, Giacomo Zoppini, Giovanni Benfari, Giulia Geremia, Stefano Bonapace, Enzo Bonora, Corrado Vassanelli, Maurice Enriquez-Sarano, Giovanni Targher
- Physical Activity in Obese Type 2 Diabetes After Gastric Bypass or Medical Management
- Jennifer Panosian, Su-Ann Ding, Marlene Wewalka, Donald C. Simonson, Ann Goebel-Fabbri, Kathleen Foster, Florencia Halperin, Ashley Vernon, Allison B. Goldfine
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?